The efficacy data could help cushion Ibrance's losses of market share to Kisqali, a similar drug from Novartis.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

Pfizer, facing increasing pressure from Novartis, is touting a Phase III win for Ibrance as the first clinical evidence supporting the CDK4/6 inhibitor class’ use in patients with a specific type of ...

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

Metastatic breast cancer diagnoses are rising in U.S. women, especially in younger age groups and racial minorities, as ...

DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.

Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is also the active ingredient in over-the-counter Rogaine. The prescription treatment is known, however, to dilate blood ...

Two studies suggest that early breast cancer patients can safely avoid specific surgeries, including lymph node removal, and ...

What started as a routine overnight trip to Edmonton in 2015 turned into a life-altering journey for Lianne Mantla-Look, a ...